These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3906417)

  • 1. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia.
    Rocić B; Breyer D; Granić M; Milutinović S
    Horm Metab Res; 1991 Oct; 23(10):490-4. PubMed ID: 1761280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
    Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
    Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of insulin binding to erythrocytes in plasma of uremic patients.
    Milutinović S; Breyer D; Janković N; Molnar V; Stefović A; Rocić B
    Nephron; 1983; 34(2):99-103. PubMed ID: 6346120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of methylguanidine on insulin binding to its receptor. Mechanism underlying insulin resistance in uremia.
    Lee JY; Iwama N; Watarai T; Yamasaki Y; Kawamori R; Kamada T
    Diabetes Res Clin Pract; 1991 Sep; 13(3):173-80. PubMed ID: 1959480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis.
    Ferrannini E; Pilo A; Tuoni M
    Metabolism; 1979 Feb; 28(2):125-36. PubMed ID: 763147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor of erythrocytes and glucose metabolism in uremic children.
    Namikawa T; Namikawa T; Fujimoto S; Furuse A; Hattori S; Matsuda I; Nakahara C; Ito H
    Horm Metab Res; 1983 Apr; 15(4):161-6. PubMed ID: 6345310
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
    Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
    Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
    [No Abstract]   [Full Text] [Related]  

  • 9. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
    Marttinen A; Pasternack A; Koivula T
    Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dialysis treatment on glucose metabolism in uremic patients.
    Kaneda H; Mimura N
    Tohoku J Exp Med; 1977 May; 122(1):35-42. PubMed ID: 918954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hemodialysis on guanidinopropionic acid metabolism.
    Gurreri G; Ghiggeri G; Salvidio G; Garibotto G; Robaudo C; Deferrari G
    Nephron; 1986; 42(4):295-7. PubMed ID: 3960241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin binding and glycolytic activity in erythrocytes from dialyzed and nondialyzed uremic patients.
    Weisinger JR; Contreras NE; Cajias J; Bellorin-Font E; Amair P; Guitierrez L; Sylva V; Paz-Martínez V
    Nephron; 1988; 48(3):190-6. PubMed ID: 3352846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retention of medium sized molecules in uremic serum].
    Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
    Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
    Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
    Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia.
    Bonomini V; Stefoni S; Casciani CU; Taccone Gallucci M; Albertazzi A; Cappelli P; Mioli V; Boggi R; Mastrangelo F; Rizzelli S
    Contrib Nephrol; 1982; 29():133-42. PubMed ID: 7075212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
    Ibels SL; Reardon MF; Nestel PJ
    J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance in the uremic patient: effects of hemodialysis].
    Sechi LA; Melis A; Pala A; Orecchioni C; Tedde R
    Boll Soc Ital Biol Sper; 1990 Oct; 66(10):993-9. PubMed ID: 2096883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte Li-Na countertransport in uremic patients: effect of urea.
    Sun YF; Tsai CJ; Hsieh CC; Lau YT
    Chin J Physiol; 1996; 39(3):177-81. PubMed ID: 8955564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.